Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

Fig. 1

Expression of BMP2 is increased within the liver of NAFLD patients. A and B Hepatic BMP2 mRNA levels determined by RT-qPCR and normalized to 36B4 gene expression. Data are expressed as fold increase relative to control condition [1] and presented as mean ± SD. C. Correlation in the study population of matched mRNA expression levels (BMP2 and CD36). Study population: Normal liver (NL) individuals (n = 75), NAFLD patients (n = 115: 56 NAFL and 59 NASH). *p < 0.05 and ***p < 0.005, NAFLD, NAFL or NASH vs. NL; ##p < 0.01, NASH vs. NAFL

Back to article page